This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Dual Time Point PET Imaging in Lymphoma

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified January 2006 by Royal Marsden NHS Foundation Trust.
Recruitment status was:  Not yet recruiting
Information provided by:
Royal Marsden NHS Foundation Trust Identifier:
First received: February 27, 2006
Last updated: October 10, 2006
Last verified: January 2006
Comparison of single time point with dual time point PET imaging in the accuracy of diagnosing active lymphoma. Biopsy results or clinical/radiological progression will be used in conjunction with the PET data.

Hodgkin's or Non-Hodgkin's Lymphoma

Study Type: Observational
Study Design: Observational Model: Defined Population
Time Perspective: Cross-Sectional
Time Perspective: Prospective

Resource links provided by NLM:

Further study details as provided by Royal Marsden NHS Foundation Trust:


Ages Eligible for Study:   16 Years and older   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

- Age 16 and above Diagnosis of Hodgkin's or Non-Hodgkin's lymphoma PET scan scheduled as part of management

Exclusion Criteria:

  • Pregnant or lactating Diabetes mellitus
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00297557

Contact: Dr Gary Cook 020 8661 3921

Sponsors and Collaborators
Royal Marsden NHS Foundation Trust
Principal Investigator: Dr Gary Cook Royal Marsden NHS Foundation Trust
  More Information Identifier: NCT00297557     History of Changes
Other Study ID Numbers: CCR2733
Study First Received: February 27, 2006
Last Updated: October 10, 2006

Additional relevant MeSH terms:
Lymphoma, Non-Hodgkin
Neoplasms by Histologic Type
Lymphoproliferative Disorders
Lymphatic Diseases
Immunoproliferative Disorders
Immune System Diseases processed this record on September 20, 2017